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Left ventricular restoration for ischemic
cardiomyopathy and simultaneous implantation of
left ventricular assist system actively aiming at
bridge to recovery
Goro Matsumiya, MD, Yuji Miyamoto, MD, Osamu Monta, MD,
Hiroshi Takano, MD, Yoshiki Sawa, MD, and Hikaru Matsuda, MD, Osaka, Japan
Left ventricular restoration (LVR) is a useful treatmentoption for ischemic cardiomyopathy (ICM). However,its current indication is limited for those with relativelystable congestive heart failure symptoms and preserved
end-organ function.1,2 We report the case of a patient with ICM
with cardiogenic shock and end-organ dysfunction who underwent
LVR and implantation of a left ventricular assist system (LVAS)
as a scheduled operation actively aiming at bridge to recovery.
Clinical Summary
A 31-year-old man with Marfan syndrome had Stanford type A
aortic dissection, which involved the left main trunk. Although he
successfully underwent valve-sparing aortic root replacement, a
large myocardial infarction developed. In the next 3 months his
condition progressed to New York Heart Association class IV
congestive heart failure. Despite multiple inotropic supports, he-
modynamic measurements showed a systolic pulmonary artery
pressure of 55 mm Hg and cardiac index of 1.6 L · min · m2.
Echocardiogram (Figure 1) showed a left ventricular (LV) diastol-
ic/systolic dimension of 71/64 mm, a left ventricular ejection
fraction of 19%, and moderate mitral regurgitation. Cardiogenic
shock, oliguria, and hepatic dysfunction (total bilirubin 5.6 mg/dL)
eventually developed in the patient, and he was brought to an
operating room.
With the use of cardiopulmonary bypass (CPB) and cardiople-
gic cardiac arrest, mitral annuloplasty was performed using a
26-mm Physio ring (Edwards Lifesciences, Irvine, Calif). Through
the longitudinal left ventriculotomy, a Dacron patch (2.5 cm wide)
was sutured to the margin of the infarcted area at the septum and
lateral wall. The ventriculotomy line was closed over the patch
leaving the apical area open for the LVAS cannula. An outflow
graft was sutured to the side of the graft at the ascending aorta. With
an extracorporeal-type
LVAS (Toyobo-NCVC,
Nipro, Japan) support,
the patient was success-
fully weaned from CPB.
The patient’s end-
organ function recov-
ered gradually; echo-
cardiographic parameters (Figure 1) and brain natriuretic
peptide level improved with time (Figure 2). Cardiac function
was assessed 70 days after the operation. During the temporal
LVAS halt, hemodynamic parameters showed no deterioration,
and left ventricular ejection fraction and cardiac index im-
proved with the increasing dose of dobutamine. After 78 days of
support, the LVAS was explanted successfully. Although there
was a transient increase of brain natriuretic peptide, the echo-
cardiogram showed consistent improvement of LV function
after the LVAS explantation (Figure 2). He is doing well with
New York Heart Association class II symptoms at 1 year since
the LVAS removal.
Discussion
Early experiences of LVR for ICM demonstrated poor out-
comes in emergency cases complicated with cardiogenic shock
and/or end-organ dysfunction.1 In such cases, the implantation
of an LVAS and subsequent heart transplantation are generally
indicated. The bridge use of an LVAS for myocardial recovery
is reported in patients with idiopathic dilated cardiomyopathy,
but patients with ICM have little chance of recovery with only
an LVAS.
There would be 2 scenarios in which patients with ICM expe-
rience cardiogenic shock.2 One is acute myocardial infarction in
the remaining viable areas. The other is progressive remodeling
and resultant failure of remaining myocardium. In the latter sce-
nario, LVR has a potential power to recover LV function. How-
ever, end-organ dysfunction after cardiogenic shock is often hard
to overcome by the restored LV that has only marginal function.
An LVAS can afford potent circulatory support for a prolonged
period and provide a good chance of end-organ recovery.
There may be several other treatment options. First, intra-aortic
balloon pump and/or extracorporeal life support as a short-term
assist after the LVR may have the limited power to reverse the
end-organ dysfunction. The other is the implantation of an LVAS
followed by the LVAS removal together with the LVR. With this
strategy, it may be difficult to assess the reversibility of the LV
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during the LVAS support. Furthermore, the use of cardiac arrest
and CPB at the LVAS removal may cause significant damage to
the impaired myocardium.
In summary, simultaneous LVR and LVAS implantation aim-
ing at myocardial recovery is one of the treatment options for ICM
complicated with cardiogenic shock and end-organ dysfunction.
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Figure 1. Short-access and M-mode view of the left ventricle (LV) by echocardiogram (A) before the left ventricular
restoration (LVR) and left ventricular assist system (LVAS) implantation, (B) just before the successful LVAS
removal, and (C) at the sixth month after the LVAS removal. The reduction of diastolic dimension and improvement
of contraction at the posterior wall were noted after the operation and persisted after the LVAS explantation. LVDd,
Left ventricular end-diastolic dimension; FS, fractional shortening.
Figure 2. Change of serum brain natriuretic peptide level and echocardiographic parameters before and after the
LVR and LVAS implantation and after the LVAS explantation. LVDd, Left ventricular end-diastolic dimension; LVEF,
left ventricular ejection fraction.
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